Albany Molecular Research, Inc. (Nasdaq: AMRI), a global drug discovery company, provides chemistry services to pharmaceutical and biotechnology companies and conducts its own proprietary research. Through its chemistry services platform, AMRI provides integrated technologies such as lead-seeking libraries, high-throughput screening, medicinal chemistry, chemical and bioprocess development, drug metabolism testing, and cGMP manufacturing. Through its proprietary R&D platform, AMRI develops preclinical or clinical drug candidates, with the goal of licensing them to a development partner.
